Checkpoint Inhibitors Show Promise against Aggressive Pediatric Brain Cancer

Immunotherapy continues to prove its mettle in the fight against various forms adult cancers ranging from melanoma to lung cancer, to kidney cancer and more. For instance, drugs that target immune checkpoint pathways, such as PD-1, help remove the genetic blindfold that cancer uses to hide from the immune system. Now, PD-1 inhibitors are entering clinical trials to treat childhood cancers, and investigators at the University of Colorado Cancer Center have new data that they believe groundwork fo